| Generic Name | Prednisolone |
|---|---|
| Drug Class | Corticosteroid (Intermediate-acting glucocorticoid) |
| Indications |
|
| Mechanism of Action | Suppresses inflammation and immune response by inhibiting cytokines, prostaglandins, and leukocyte migration; moderate mineralocorticoid activity. |
| Available Forms & Strengths | • Tablet: 1 mg, 5 mg, 10 mg, 20 mg • Syrup: 5 mg/5 mL, 15 mg/5 mL • Dispersible tablet: 5 mg |
| Dosage | Adults: 5–60 mg/day orally (single or divided doses) Children: 1–2 mg/kg/day (max 60 mg/day, depending on indication) |
| Route | Oral |
| Common Side Effects |
|
| Serious Adverse Effects | Adrenal suppression, infections, hypertension, GI bleeding, osteoporosis, growth suppression (children) |
| Contraindications | • Systemic fungal infections • Hypersensitivity to prednisolone |
| Precautions | • Diabetes mellitus • Hypertension, heart failure • Peptic ulcer disease • Tuberculosis or latent infections |
| Drug Interactions | • NSAIDs (↑ GI bleeding risk) • Rifampicin, phenytoin (↓ steroid effect) • Live vaccines (avoid) |
| Pregnancy & Lactation | Pregnancy: Generally safe when indicated Lactation: Compatible; monitor infant with high doses |
| Storage | Store below 30°C, protect from moisture and light |
| References | BNF | BNF for Children | Goodman & Gilman |